Reaction
Enterobacter Bacteraemia reporting signals
As of the last recalculation, Enterobacter Bacteraemia appears in 298 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is POSACONAZOLE (PRR 112.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Posaconazole | 24 | 112.1 | 112.3 |
| Mesna Injection | 11 | 96.5 | 96.6 |
| Mesna | 11 | 94.7 | 94.8 |
| Busulfan | 19 | 90.0 | 90.1 |
| Posaconazole Delayed-Release | 9 | 59.0 | 59.0 |
| Dronabinol | 6 | 53.2 | 53.2 |
| Pegaspargase | 9 | 52.9 | 52.9 |
| Fludarabine Phosphate | 26 | 50.5 | 50.5 |
| Fosaprepitant Dimeglumine | 9 | 47.1 | 47.1 |
| Mercaptopurine | 11 | 46.0 | 46.0 |
| Vincristine Sulfate | 16 | 40.2 | 40.3 |
| Cefepime Hydrochloride | 9 | 40.2 | 40.2 |
| Cefepime | 8 | 40.0 | 40.0 |
| Thiotepa | 5 | 37.2 | 37.2 |
| Bleomycin Sulfate | 5 | 34.4 | 34.4 |
| Azacitidine For | 8 | 31.5 | 31.6 |
| Daptomycin | 3 | 22.9 | 22.9 |